Mixed but not to shabby
$Gritstone Bio(GRTS.US$ Gritstone Bio (NASDAQ:GRTS) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.31) by 9.68 percent. This is a 13.33 percent decrease over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $1.742 million which beat the analyst consensus estimate of $1.104 million by 57.77 percent. This is a 28.69 percent decrease over sales of $2.443 million the same period last year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
